TriSalus Life Sciences Warrant
TLSIW
8 hedge funds and large institutions have $1.77M invested in TriSalus Life Sciences Warrant in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
424% more capital invested
Capital invested by funds: $337K → $1.77M (+$1.43M)
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
100% more funds holding
Funds holding: 4 → 8 (+4)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| 1 |
Cerity Partners
New York
|
+$1.05M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$39.5K |
| 3 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$35.8K |
| 4 |
FBCM
Fort Baker Capital Management
Larkspur,
California
|
+$33.7K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.28K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$61.9K |
| 2 |
ACM
Alpha Capital Management
Austin,
Texas
|
-$18.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Cerity Partners
New York
| $1.37M | +$1.05M | +827,590 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $129K | -$61.9K | -48,593 | -38% |
|
|
VI
3
Vestcor Inc
Fredericton,
New Brunswick, Canada
| $117K | – | – | – |
|
|
WAM
4
Wolverine Asset Management
Chicago,
Illinois
| $51.4K | +$39.5K | +30,990 | New |
|
|
FBCM
5
Fort Baker Capital Management
Larkspur,
California
| $43.9K | +$33.7K | +26,474 | New |
|
|
AC
6
Aristeia Capital
Greenwich,
Connecticut
| $42.7K | +$35.8K | +28,066 | New |
|
7
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $7.86K | – | – | – |
|
|
8
Bank of America
Charlotte,
North Carolina
| $1.68K | +$1.28K | +1,009 | New |
|
|
ACM
9
Alpha Capital Management
Austin,
Texas
| – | -$18.7K | -11,000 | Closed |
|
TLSIW Hedge Fund Activity: Q4 2025 in Review
8 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q4 2025, worth a combined $1.77M — up 424% from $337K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new TLSIW positions and 1 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Cerity Partners, opening a new position worth an estimated $1.05M. The largest seller was Citadel Advisors, cutting an estimated $61.9K.
- 8 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q4 2025, up from 4 in Q3 2025.
- Funds reported $1.77M of TriSalus Life Sciences Warrant stock for Q4 2025, up 424% quarter-over-quarter.
- 5 funds opened new TriSalus Life Sciences Warrant positions in Q4 2025 and 1 closed out, a net change of +4 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q4 2025 was Cerity Partners, an estimated $1.05M added.
- The largest TriSalus Life Sciences Warrant seller in Q4 2025 was Citadel Advisors, an estimated $61.9K sold.
Based on aggregated 13F filings for Q4 2025.